(Q40639964)

22 September 2017

title

Type II secretory phospholipase A2 binds to ischemic flip-flopped cardiomyocytes and subsequently induces cell death (English)

1 reference

22 September 2017

R Nijmeijer

1

1 reference

22 September 2017

M Willemsen

2

1 reference

22 September 2017

C J L M Meijer

3

1 reference

22 September 2017

C A Visser

4

1 reference

22 September 2017

R H Verheijen

5

1 reference

22 September 2017

R A Gottlieb

6

1 reference

22 September 2017

C E Hack

7

1 reference

22 September 2017

H W M Niessen

8

1 reference

22 September 2017

publication date

12 June 2003

1 reference

American Journal of Physiology Heart and Circulatory Physiology

22 September 2017

published in

1 reference

22 September 2017

volume

285

1 reference

22 September 2017

issue

5

1 reference

22 September 2017

page(s)

H2218-24

1 reference

Distinct roles in signal transduction for each of the phospholipase A2 enzymes present in P388D1 macrophages.

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2002

Ischemic-reperfused isolated working mouse hearts: membrane damage and type IIA phospholipase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2002

Phospholipase A2 enzymes: regulation and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2002

The complement system in myocardial ischaemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2002

Circulating levels of secretory type II phospholipase A(2) predict coronary events in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2002

C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2002

Irreversible inhibition of Ca(2+)-independent phospholipase A2 by methyl arachidonyl fluorophosphonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2002

Structure-based design of a new class of anti-inflammatory drugs: secretory phospholipase A(2) inhibitors, SPI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2002

Prime causes of rapid cardiomyocyte death during reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2002

New colorimetric cytotoxicity assay for anticancer-drug screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2002

Inhibition of sodium and calcium overload pathology in the myocardium: a new cytoprotective principle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2002

New mechanisms by which secretory phospholipase A2 stimulates neutrophils to provoke the release of cytotoxic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00887.2002

10.1152/AJPHEART.00887.2002

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference